The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

April 30, 2008

Conditions
Leprosy
Interventions
PROCEDURE

Routine treatment

Subjects from the Control Group received routine treatment, including daily simple dressings with sterile gauze after wound cleaning with a 0.9% physiologic solution, use of 1% hydrophilic silver sulfadiazine cream (Prati Donaduzzi Laboratory, Toledo, Brazil) and orientation about the use of adapted footwear, self-care and the prevention of disabilities. Surgical debridement was done whenever indicated by nursing or orthopedic services from UREMC.

RADIATION

Low level laser therapy (LLLT)

"The LLLT equipment was an indium-gallium-aluminnium-phosphide (InGaAlP) semiconductor laser with a maximum output power of 40 mW, continuous radiation emission of visible red light with 660 nm wavelength (+/- 10 nm) and a spot area of 0.04 cm². The energy density used was 4 J per point in the wound edges and 2 J/cm² in the wound bed with a power density of 1 W/cm2.~Wound beds were irradiated using a scanning technique with no direct contact."

Trial Locations (1)

67200-000

Dr. Marcello Candia Reference Unit in Sanitary Dermatology of the State of Pará in Brazil (UREMC), Marituba

All Listed Sponsors
lead

Para Federal University

OTHER

NCT00860717 - The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients | Biotech Hunter | Biotech Hunter